The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation

American Journal of Clinical Pathology

Volumn 111, Issue 1 SUPPL. 1, 1999, Pages

  Kinney, Marsha C ^a   Kadin, Marshall E ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

ALK; Anaplastic large cell lymphoma; CD30; Ki 1; Lymphomatoid papulosis; p80

Indexed keywords

ANAPLASTIC CARCINOMA; CANCER CLASSIFICATION; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 5; CORRELATION FUNCTION; CYTOGENETICS; HUMAN; LARGE CELL LYMPHOMA; MOLECULAR CLONING; PRIORITY JOURNAL; REVIEW;

CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, KI-1; PROTEIN-TYROSINE KINASES; TRANSLOCATION, GENETIC;

EID: 0032902245     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848-858.
2. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998;91:2076-2084.
3. Le Beau MM, Bitter MA, Larson RA, et al. The t(2;5)(p23;q35); a recurring chromosomal abnormality in Ki-1-positive anaplastic large-cell lymphoma. Leukemia. 1989;3:866-890.
4. Rimokh R, Magaud J-P, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ("Ki-1 lymphoma"). Br J Haematol. 1989;71:31-36.
5. Kaneko Y, Frizzera G, Edamura S, et al. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood. 1989;73:806-613.
6. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994;263:1281-1284.
7. Bischof D, Pulford K, Mason DY, et al. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol. 1998;17: 2312-2325.
8. Kuefer MU, Look AT, Pulford K, et al. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood. 1998;90:2901-2910.
9. Shiota M, Fujimoto J, Takenaga M, et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood. 1994;84:3648-3652.
10. NPM/ALK: a distinct clinicopathologic entity. Blood. 1995;86:1954-1960.
11. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394-1404.
12. Agnarsson BA, Kadin ME. Ki-1-positive large-cell lymphoma: a morphologic and immunologic analysis of 19 cases. Am J Surg Pathol. 1988;21:264-274.
13. Foss H-D, Anagnostopoulos I, Araujo I, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood. 1996;88:4005-4011.
14. Delsol G, Al Saati T, Gatter KC, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large-cell lymphomas: diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988;130: 59-70.
15. Chott A, Kaserer K, Augustin I, et al. Ki-1-positive large-cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol. 1990;14:439-448.
16. Chan JKC, Ng CS, Hui PK, et al. Anaplastic large cell Ki-1 lymphoma: delineation of two morphological types. Histopathology. 1989;15:11-34.
17. + with a high content of reactive histiocytes. Histopathology. 1990;16:383-391.
18. Kadin ME. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv. 1997;30:77-86.
19. + T-cell lymphoma. Am J Surg Pathol. 1993;17:859-868.
20. Weisenburger DD, Gordon BG, Vose JM, et al. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood. 1996;87:3860-3868.
21. + lymphomas: histologic and immunophenotypic correlation [abstract]. Lab Invest. 1996;74:114A.
22. + lymphoma (SCV) to anaplastic large cell lymphoma (ALCL): pathologic and clinical features. Am J Surg Pathol. In press.
23. Pileri S, Sabattini E, Falini B. Lymphohistiocytic T-cell lymphoma and peripheral T-cell lymphoma associated with haemophagocytic syndrome: two recently recognized entities which mimic malignant histiocytosis. Leuk Lymphoma. 1992;6:317-324.
24. Chan JKC, Buchanan R, Fletcher CDM. Sarcomatoid variant of anaplastic large cell Ki-1 lymphoma. Am J Surg Pathol. 1990;14:383-390.
25. + anaplastic large-cell lymphoma, null type, with signet-ring appearance. Histopathology. 1997;30:90-92.
26. Bellas C, Molina A, Montalban C, et al. Signet-ring cell lymphoma of T-cell type with CD30 expression. Histopathology. 1993;22:188-189.
27. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 1994;84:1361-1392.
28. Pileri S, Mazza P, Zinzani PL, et al. Ki-1 lymphoma and Hodgkin's disease. Haematologica (Pavia). 1989;74:333-334.
29. Frizzera G. The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Semin Diagn Pathol. 1992;9:291-296.
30. Stein H, Herbst H, Anagnostopoulos I, et al. The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann Oncol. 1991;2(suppl):33-38.
31. Leoncini L, Del Vecchio MT, Kraft R, et al. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas: a continuous spectrum of malignant disorders: a quantitative morphometric and immunohistologic study. Am J Pathol. 1990;137:1047-1057.
32. Elmberger PG, Lozano MD, Weisenburger DD, et al. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood. 1995;86:3517-3521.
33. + anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood. 1995;86: 2321-2328.
34. Sarris AH, Luthra R, Papadimitracopoulou V, et al. Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood. 1996;88:1771-1779.
35. Herbst H, Anagnostopoulos I, Heinze B, et al. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood. 1995;86:1694-1700.
36. Lamant L, Meggetto F, Al Saati T, et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood. 1996;87:284-291.
37. Yee HT, Ponzoni M, Merson A, et al. Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood. 1996;87:1081-1088.
38. + primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood. 1996;88:1765-1770.
39. Zuckerberg LR, Collins AB, Ferry JA, et al. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol. 1991;139:475-483.
40. Schmid C, Pan L, Diss T, et al. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol. 1991;139:701-707.
41. Pittaluga S, Wlodarska I, Pulford K, et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol. 1997;151:343-351.
42. Murphy SB. Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhood. Ann Oncol. 1994;5:S31-S33.
43. + large-cell non-Hodgkin's lymphoma. J Clin Oncol. 1994;12:895-898.
44. Greer JP, Kinney MC, Collins RD, et al. Clinical features of 31 patients with Ki-1 anaplastic large cell lymphoma. J Clin Oncol. 1991;9:539-547.
45. Greer JP, Whitlock JA, Kinney MC. Ki-1 positive anaplastic large cell lymphoma: a useful concept? In: Armitage J, Newland A, Keating A, et al, eds. Cambridge Medical Reviews: Haematological Oncology. Vol 4. Cambridge, England: Cambridge University Press; 1995;89-117.
46. Tilly H, Gaulard P, Lepage E, et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood. 1997;90:3727-3734.
47. Schulman LN, Frisard B, Antin JH, et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol. 1993;11:937-942.
48. +): results of a prospective clinicopathological study of 69 cases. Br J Hoematol. 1994;86:513-523.
49. Romaguera JE, Manning JT Jr, Tornos CS, et al. Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma. Ann Oncol. 1994;5:317-322.
50. Kadin ME. Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity, 1994;5(suppl 1):S25-S30.
51. Fanin R, Silvestri F, Geromin A, et al. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treament with the F-MACHOP regimen (±radiotherapy) and autologous bone marrow transplantation. Blood. 1996;87:1243-1248.
52. Filippa DA, Ladanyi M, Wollner N, et al. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood. 1996;87:2905-2917.
53. Reiter A, Schrappe M, Tiemann M, et al. Successful treament strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol. 1994;12:899-908.
54. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis: a European multicenter study of 47 patients. Cancer. 1993;71: 2097-2104.
55. + anaplastic large cell lymphomas. Semin Dermatol. 1994;13:180-186.
56. De Bruin PC, Beljaards RC, Van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology. 1993;23:127-135.
57. Krishnan J, Tomaszewski M-M, Kao GF. Primary cutaneous CD30-positive anaplastic large cell lymphoma report of 27 cases. J Cutan Pathol. 1993;20:193-202.
58. Paulli M, Berti E, Rosso R, et al. CD30/Kt-1-positive lymphoproliferative disorders of the skin: clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol. 1995;13:1343-1354.
59. Macgrogan G, Vergier B, Dubus P, et al. CD30-positive cutaneous large cell lymphomas: a comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol. 1996;105:440-450.
60. Demierre M-F, Goldberg LJ, Kadin ME, et al. Is it lymphoma or lymphomatoid papulosis.? J Am Acad Dermatol. 1997;36:765-772.
61. Lindholm JS, Barron DR, Williams ME, et al. Ki-1-positive cutaneous large cell lymphoma of T-cell type: report of an indolent subtype. J Am Acad Dermatol 1989;20:342-348.
62. Tomaszewski M-M, Lupton GP, Krishnan J, et al. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1) positive anaplastic large cell lymphoma. J Cutan Pathol. 1995;22:310-318.
63. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354-371.
64. Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. J Am Acad Dermatol. 1993;28:973-980.
65. Tirelli U, Vaccher E, Zagonel V, et al. CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol. 1995;13:373-380.
66. Kerschmann RL, Berger TG, Weiss LM, et al. Cutaneous presentations of lymphoma in human immunodeficiency virus disease: predominance of T-cell lineage. Arch Dematol. 1995;131:1281-1288.
67. Chadburn A, Cesarman E, Jagirdar J, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer. 1993;72:3078-3090.
68. + patients: clinical and pathological findings in a group often patients. Br J Haematol. 1996;95:508-512.
69. +) anaplastic large cell lymphomas: morphologic, immunohistologic, and clinical characteristics. Am J Pathol. 1989;135:359-367.
70. NPM/ALK expression. Am J Surg Pathol. 1997;21:1420-1432.
71. + lymphomas from American and Asian patients: a reverse transcriptase-polymerase chain reaction study. Am J Pathol. 1995;146:323-328.
72. Arber DA, Sun L-H, Weiss LM. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Hum Pathol. 1996;27:590-594.
73. Downing JR, Shurtleff SA, Zielenska M, et al. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood. 1995;85:3416-3422.
74. Alsabeth R, Medeiros LJ, Glackin C, et al. Transformation of follicular lymphoma into CD30-large cell lymphoma with anaplastic cytologic features. Am J Surg Pathol. 1997;21:528-536.
75. Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood. 1997;89:1483-1490.
76. + lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996;87:3437-3441.
77. Beylot-Barry M, Lamant L, Vergier B, et al. Detection of the t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol. 1996;149:483-492.
78. Simonitsch I, Panzer-Gruemayer ER, Ghali DW, et al. NPM/ALK gene fusion transcripts identify a distinct subgroup of null type Ki-1 positive anaplastic large cell lymphomas. Br J Haematol. 1996;92:866-871.
79. Fonatsch C, Latza U, Dürkop H, et al. Assignment of the human CD30 (Ki-1) gene to 1p36. Genomics. 1992;14: 825-826.